Elizabeth M Smith

This inventor holds 45 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Pharmacopeia Drug Discovery, Inc.. Active years: 1984-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth M Smith. Retrieved from https://idiyas.com/inventor/elizabeth-m-smith

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 45 (Patent Applications = 3)

% Patents Active = 88.9

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 3)

Average Co-Inventor Count = 4.8

ph-index = 16

Forward Citations = 748(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

4 out of 52

Pharmacopeia Drug Discovery, Inc.

Pharacopeia Drug Discovery, Inc.

patent

6. 1 out of 28

Schering-Plough Corporation

patents

where one patent can have more than one assignee

Years Active: 1984-2020

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Aspartyl Protease Inhibitors

CCR5 Antagonists

Gamma Secretase Inhibitors

Azetidinone Derivatives

Piperazine Derivatives

Antihypertensives

Bicyclic Guanidine Derivatives

Anti-Cancer Agents

Antiglaucoma Compositions

Angiotensin-Converting Enzyme Inhibitors

Carboxyalkyl Dipeptides

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10696639 - Heterocyclic compounds as HIV protease inhibitors (2020-06-30),

2. 8829036 - Heterocyclic aspartyl protease inhibitors (2014-09-09),

3. 8778980 - Heterocyclic aspartyl protease inhibitors (2014-07-15),

4. 8691833 - Heterocyclic aspartyl protease inhibitors (2014-04-08),

5. 8691831 - Heterocyclic aspartyl protease inhibitors (2014-04-08),

6. 8685967 - Substituted triazolopyridines and analogs thereof (2014-04-01),

7. 8242112 - Heterocyclic aspartyl protease inhibitors (2012-08-14),

8. 8178513 - Heterocyclic aspartyl protease inhibitors (2012-05-15),

9. 8114879 - Piperazine derivatives useful as CCR5 antagonists (2012-02-14),

10. 8110682 - Preparation and use of compounds as aspartyl protease inhibitors (2012-02-07),

11. 7973067 - Heterocyclic aspartyl protease inhibitors (2011-07-05),

12. 7884080 - Azetidinone derivatives and methods of use thereof (2011-02-08),

13. 7763609 - Heterocyclic aspartyl protease inhibitors (2010-07-27),

14. 7759354 - Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof (2010-07-20),

15. 7700603 - Heterocyclic aspartyl protease inhibitors (2010-04-20),

Title: The Innovative Journey of Elizabeth M Smith

Introduction: Elizabeth M Smith, a pioneering inventor hailing from Verona, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Elizabeth M Smith's latest patents include groundbreaking inventions in the field of renewable energy storage systems and sustainable packaging solutions.

Career Highlights: With a career spanning over two decades, Elizabeth M Smith has established herself as a leading figure in the innovation landscape. Her work has been instrumental in shaping the future of clean technology and environmental sustainability.

Collaborations: Throughout her career, Elizabeth M Smith has collaborated with top research institutions, universities, and leading companies to bring her innovative ideas to life. Her partnerships have led to the development of cutting-edge technologies that have revolutionized various industries.

Conclusion: Elizabeth M Smith's passion for innovation and commitment to creating a more sustainable world have solidified her position as a trailblazer in the field of inventions. Her work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.